Evidence map›Paper›PMID 35069234›Full record

ArticleFrontiers in physiology2021

Effects of Circadian Phase Tailored Light Therapy on Sleep, Mood, and Cognition in Alzheimer's Disease: Preliminary Findings in a Pivotal Study.

Riccardo Cremascoli, Davide Sparasci, Gianluca Giusti, Stefania Cattaldo, Elisa Prina, Fausto Roveta, Francesco Bruno, Cristina Ghezzi, Silvia Cerri, Marta Picascia and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 5 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 5 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Riccardo CremascoliDepartment of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy.
Davide SparasciDepartment of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy.
Gianluca GiustiDepartment of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy.
Stefania CattaldoLaboratory of Clinical Neurobiology, Istituto Auxologico Italiano, IRCCS, San Giuseppe Hospital, Piancavallo, Italy.
Elisa PrinaLaboratory of Clinical Neurobiology, Istituto Auxologico Italiano, IRCCS, San Giuseppe Hospital, Piancavallo, Italy.
Fausto RovetaDepartment of Neurosciences "Rita Levi Montalcini", University of Torino, Turin, Italy.
Francesco BrunoDepartment of Neurosciences "Rita Levi Montalcini", University of Torino, Turin, Italy.
Cristina GhezziLaboratory of Functional Neurochemistry, IRCCS Mondino Foundation, Pavia, Italy.
Silvia CerriLaboratory of Functional Neurochemistry, IRCCS Mondino Foundation, Pavia, Italy.
Marta PicasciaNeuropsychology/Alzheimer's Disease Assessment Unit, IRCCS Mondino Foundation, Pavia, Italy.
Sara BerniniNeuropsychology/Alzheimer's Disease Assessment Unit, IRCCS Mondino Foundation, Pavia, Italy.
Elena SinforianiNeuropsychology/Alzheimer's Disease Assessment Unit, IRCCS Mondino Foundation, Pavia, Italy.
Michele TerzaghiDepartment of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy.
Lorenzo PrianoDepartment of Neurology and Neurorehabilitation, Istituto Auxologico Italiano, IRCCS, San Giuseppe Hospital, Piancavallo, Italy.
Alessandro MauroDepartment of Neurology and Neurorehabilitation, Istituto Auxologico Italiano, IRCCS, San Giuseppe Hospital, Piancavallo, Italy.
Raffaele ManniUnit of Sleep Medicine and Epilepsy, IRCCS Mondino Foundation, Pavia, Italy.
IRCCS Istituto Auxologico Italiano · ITUniversity of Pavia · ITUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is shown that the circadian system is affected in patients with Alzheimer's disease (AD) even at an early stage of the disease and that such dysfunction may be detrimental to sleep, mood, and cognitive functioning. Light is a strong central modulator of the circadian rhythms and is potentially beneficial to mood and cognitive functioning

Indexed as

Alzheimer’s diseasecircadian rhythmcognitiondim light melatonin onset (DLMO)light therapymelatoninsleep quality

Identifiers

PMID35069234
PMCPMC8770402
OpenAlexW4206815297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.